메뉴 건너뛰기




Volumn 19, Issue 4, 2003, Pages 291-297

Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products

Author keywords

Amoxicillin capsules; ASA boluses; Carbamazepine tablets; Setting dissolution specifications; USP apparatuses

Indexed keywords

CARBOXYLIC ACIDS; DISSOLUTION; ETHANOL; PHOSPHATES;

EID: 0041667785     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00120-9     Document Type: Article
Times cited : (22)

References (22)
  • 1
    • 0028907748 scopus 로고
    • Evaluation of the performance of prednisone and salicylic acid calibrators
    • Achanta A.S., Gray V.A., Cecil T.L., Grady L.T. Evaluation of the performance of prednisone and salicylic acid calibrators. Drug Dev. Ind. Pharm. 21:1995;1171-1182.
    • (1995) Drug Dev. Ind. Pharm. , vol.21 , pp. 1171-1182
    • Achanta, A.S.1    Gray, V.A.2    Cecil, T.L.3    Grady, L.T.4
  • 3
    • 0020085526 scopus 로고
    • Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere
    • Cox D.C., Wells C.E., Furman W.B., Savage T.S., King A.C. Systematic error associated with apparatus 2 of the USP dissolution test II: effects of deviations in vessel curvature from that of a sphere. J. Pharm. Sci. 71:1982;395-399.
    • (1982) J. Pharm. Sci. , vol.71 , pp. 395-399
    • Cox, D.C.1    Wells, C.E.2    Furman, W.B.3    Savage, T.S.4    King, A.C.5
  • 4
    • 0020519879 scopus 로고
    • Systematic error associated with apparatus 2 of the USP dissolution test IV: Effect of air dissolved in the dissolution medium
    • Cox D.C., Furman W.B., Page D.P. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium. J. Pharm. Sci. 72:1983;1061-1064.
    • (1983) J. Pharm. Sci. , vol.72 , pp. 1061-1064
    • Cox, D.C.1    Furman, W.B.2    Page, D.P.3
  • 5
    • 0021232978 scopus 로고
    • Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels
    • Cox D.C., Furman W.B. Systematic error associated with apparatus 2 of the USP dissolution test V: interaction of two tableted prednisone formulations with glass and plastic vessels. J. Pharm. Sci. 73:1984;1125-1127.
    • (1984) J. Pharm. Sci. , vol.73 , pp. 1125-1127
    • Cox, D.C.1    Furman, W.B.2
  • 6
    • 0031771036 scopus 로고    scopus 로고
    • Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets
    • Eddington N.D., Ashraf M., Augsburger L.L., Leslie J.L., Fossler M.J., Lesko L.J., Shah V.P., Rekhi G.S. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets. Pharm. Dev. Technol. 3:1998;535-547.
    • (1998) Pharm. Dev. Technol. , vol.3 , pp. 535-547
    • Eddington, N.D.1    Ashraf, M.2    Augsburger, L.L.3    Leslie, J.L.4    Fossler, M.J.5    Lesko, L.J.6    Shah, V.P.7    Rekhi, G.S.8
  • 8
    • 0006967910 scopus 로고
    • Industry perspective on dissolution apparatus calibration
    • McCormick T.J. Industry perspective on dissolution apparatus calibration. Dissolution Technol. 2:1995;12-15.
    • (1995) Dissolution Technol. , vol.2 , pp. 12-15
    • McCormick, T.J.1
  • 9
    • 0033775866 scopus 로고    scopus 로고
    • Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate
    • Mahayni H., Rekhi G.S., Uppoor R.S., Marroum P., Hussain A.S., Augsburger L.L., Eddington N.D. Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate. J. Pharm. Sci. 89:2000;1354-1361.
    • (2000) J. Pharm. Sci. , vol.89 , pp. 1354-1361
    • Mahayni, H.1    Rekhi, G.S.2    Uppoor, R.S.3    Marroum, P.4    Hussain, A.S.5    Augsburger, L.L.6    Eddington, N.D.7
  • 11
    • 0006896685 scopus 로고    scopus 로고
    • Dissolution testing: Collaborative study of the in-house NCDA 2 dissolution calibrator tablets with USP apparatus 2
    • Moore T.W., Cox D.C. Dissolution testing: collaborative study of the in-house NCDA 2 dissolution calibrator tablets with USP apparatus 2. Pharmacopeial Forum. 23:1997;4250-4255.
    • (1997) Pharmacopeial Forum , vol.23 , pp. 4250-4255
    • Moore, T.W.1    Cox, D.C.2
  • 14
    • 0030926727 scopus 로고    scopus 로고
    • Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets
    • Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86:1997;690-700.
    • (1997) J. Pharm. Sci. , vol.86 , pp. 690-700
    • Polli, J.E.1    Rekhi, G.S.2    Augsburger, L.L.3    Shah, V.P.4
  • 15
    • 0028898199 scopus 로고
    • A critical assessment of the USP dissolution apparatus suitability test criteria
    • Qureshi S.A., McGilveray I.J. A critical assessment of the USP dissolution apparatus suitability test criteria. Drug Dev. Ind. Pharm. 21:1995;905-992.
    • (1995) Drug Dev. Ind. Pharm. , vol.21 , pp. 905-992
    • Qureshi, S.A.1    McGilveray, I.J.2
  • 16
    • 0032923660 scopus 로고    scopus 로고
    • Typical variability in drug dissolution testing: Study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product
    • Qureshi S.A., McGilveray S.A. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. Eur. J. Pharm. Sci. 7:1999;249-258.
    • (1999) Eur. J. Pharm. Sci. , vol.7 , pp. 249-258
    • Qureshi, S.A.1    McGilveray, S.A.2
  • 17
    • 0033674245 scopus 로고    scopus 로고
    • Cause of high variability in drug dissolution testing and its impact on setting tolerance
    • Qureshi S.A., Shabnam J. Cause of high variability in drug dissolution testing and its impact on setting tolerance. Eur. J. Pharm. Sci. 12:2001;271-276.
    • (2001) Eur. J. Pharm. Sci. , vol.12 , pp. 271-276
    • Qureshi, S.A.1    Shabnam, J.2
  • 18
    • 0031401983 scopus 로고    scopus 로고
    • Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations
    • Rekhi G.S., Eddington N.D., Fossler M.J., Schwartz P., Lesko L.J., Augsburger L.L. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Pharm. Dev. Technol. 2:1997;11-24.
    • (1997) Pharm. Dev. Technol. , vol.2 , pp. 11-24
    • Rekhi, G.S.1    Eddington, N.D.2    Fossler, M.J.3    Schwartz, P.4    Lesko, L.J.5    Augsburger, L.L.6
  • 19
    • 85031141422 scopus 로고    scopus 로고
    • Rockville, MD: United States Pharmacopeial Convention
    • USP 25. 2002;2011-2012 United States Pharmacopeial Convention, Rockville, MD.
    • (2002) USP 25 , pp. 2011-2012
  • 20
    • 85031143424 scopus 로고    scopus 로고
    • Rockville, MD: United States Pharmacopeial Convention
    • USP 25. 2002;133 United States Pharmacopeial Convention, Rockville, MD.
    • (2002) USP 25 , pp. 133
  • 21
    • 85031136886 scopus 로고    scopus 로고
    • Rockville, MD: United States Pharmacopeial Convention
    • USP 25. 2002;165 United States Pharmacopeial Convention, Rockville, MD.
    • (2002) USP 25 , pp. 165
  • 22
    • 85031139006 scopus 로고    scopus 로고
    • Rockville, MD: United States Pharmacopeial Convention
    • USP 25. 2002;302 United States Pharmacopeial Convention, Rockville, MD.
    • (2002) USP 25 , pp. 302


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.